⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBO News
Impact BioMedical, Inc.
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
globenewswire.com
IBO
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
globenewswire.com
IBO
Impact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
businesswire.com
IBO
Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
businesswire.com
IBO
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
globenewswire.com
IBO
IBIO
Form 8-K
sec.gov
IBO
Infant Biometrics Market Surges in 2026 with Fingerprint Technology Dominating 100% Share
globenewswire.com
IBO